188 related articles for article (PubMed ID: 33314720)
1. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
[TBL] [Abstract][Full Text] [Related]
2. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
[TBL] [Abstract][Full Text] [Related]
3. ADAM8 localizes to extravillous trophoblasts within the maternal-fetal interface and potentiates trophoblast cell line migration through a β1 integrin-mediated mechanism.
Le HT; Atif J; Mara DL; Castellana B; Treissman J; Baltayeva J; Beristain AG
Mol Hum Reprod; 2018 Oct; 24(10):495-509. PubMed ID: 30124911
[TBL] [Abstract][Full Text] [Related]
4. ADAM8 as a drug target in pancreatic cancer.
Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
[TBL] [Abstract][Full Text] [Related]
5. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
6. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
7. Integrin
Zhang YL; Xing X; Cai LB; Zhu L; Yang XM; Wang YH; Yang Q; Nie HZ; Zhang ZG; Li J; Zhang XL
J Immunol Res; 2018; 2018():4602570. PubMed ID: 29951557
[TBL] [Abstract][Full Text] [Related]
8. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Metalloproteinase ADAM8 Is Upregulated in Liver Inflammation Models and Enhances Cytokine Release
Awan T; Babendreyer A; Wozniak J; Alvi AM; Sterzer V; Cook L; Bartsch JW; Liedtke C; Yildiz D; Ludwig A
Mediators Inflamm; 2021; 2021():6665028. PubMed ID: 33814981
[TBL] [Abstract][Full Text] [Related]
10. A disintegrin and metalloproteinase 8 induced epithelial-mesenchymal transition to promote the invasion of colon cancer cells via TGF-β/Smad2/3 signalling pathway.
Jin Q; Jin X; Liu T; Lu X; Wang G; He N
J Cell Mol Med; 2020 Nov; 24(22):13058-13069. PubMed ID: 32954649
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
Zha R; Guo W; Zhang Z; Qiu Z; Wang Q; Ding J; Huang S; Chen T; Gu J; Yao M; He X
PLoS One; 2014; 9(2):e87665. PubMed ID: 24498348
[TBL] [Abstract][Full Text] [Related]
12. ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-κB/MMP-13 signaling axis.
Liu Y; Li ZH; Zhang L; Lu SB
Anticancer Drugs; 2019 Aug; 30(7):e0790. PubMed ID: 31305294
[TBL] [Abstract][Full Text] [Related]
13. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
[TBL] [Abstract][Full Text] [Related]
14. The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation.
Dreymueller D; Pruessmeyer J; Schumacher J; Fellendorf S; Hess FM; Seifert A; Babendreyer A; Bartsch JW; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L602-L614. PubMed ID: 28596294
[TBL] [Abstract][Full Text] [Related]
15. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
Yu X; Shi J; Wang X; Zhang F
Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
[TBL] [Abstract][Full Text] [Related]
16. Integrin-specific control of focal adhesion kinase and RhoA regulates membrane protrusion and invasion.
Costa P; Scales TM; Ivaska J; Parsons M
PLoS One; 2013; 8(9):e74659. PubMed ID: 24040310
[TBL] [Abstract][Full Text] [Related]
17. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells.
Park GB; Choi S; Yoon YS; Kim D
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846772
[TBL] [Abstract][Full Text] [Related]
18. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
[TBL] [Abstract][Full Text] [Related]
19. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
20. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
Romagnoli M; Mineva ND; Polmear M; Conrad C; Srinivasan S; Loussouarn D; Barillé-Nion S; Georgakoudi I; Dagg Á; McDermott EW; Duffy MJ; McGowan PM; Schlomann U; Parsons M; Bartsch JW; Sonenshein GE
EMBO Mol Med; 2014 Feb; 6(2):278-94. PubMed ID: 24375628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
